IL-6 treatment was shown to prompt macrophages to release miR-223-rich exosomes, which subsequently reduced the expression of the fibrosis-promoting transcriptional coactivator with PDZ-binding motif (TAZ) in hepatocytes, thereby ameliorating liver fibrosis (48). Here, IL6 is linked to Hepatic fibrosis.